The impact of health inequity on spatial variation of COVID-19 transmission in England

PLoS Comput Biol. 2024 May 28;20(5):e1012141. doi: 10.1371/journal.pcbi.1012141. eCollection 2024 May.

Abstract

Considerable spatial heterogeneity has been observed in COVID-19 transmission across administrative areas of England throughout the pandemic. This study investigates what drives these differences. We constructed a probabilistic case count model for 306 administrative areas of England across 95 weeks, fit using a Bayesian evidence synthesis framework. We incorporate the impact of acquired immunity, of spatial exportation of cases, and 16 spatially-varying socio-economic, socio-demographic, health, and mobility variables. Model comparison assesses the relative contributions of these respective mechanisms. We find that spatially-varying and time-varying differences in week-to-week transmission were definitively associated with differences in: time spent at home, variant-of-concern proportion, and adult social care funding. However, model comparison demonstrates that the impact of these terms is negligible compared to the role of spatial exportation between administrative areas. While these results confirm the impact of some, but not all, static measures of spatially-varying inequity in England, our work corroborates the finding that observed differences in disease transmission during the pandemic were predominantly driven by underlying epidemiological factors rather than aggregated metrics of demography and health inequity between areas. Further work is required to assess how health inequity more broadly contributes to these epidemiological factors.

MeSH terms

  • Bayes Theorem*
  • COVID-19* / epidemiology
  • COVID-19* / transmission
  • England / epidemiology
  • Health Status Disparities
  • Humans
  • Models, Statistical
  • Pandemics / statistics & numerical data
  • SARS-CoV-2*
  • Socioeconomic Factors

Grants and funding

TR acknowledges funding by Community Jameel and from the MRC Centre for Global Infectious Disease Analysis (reference MR/X020258/1), funded by the UK Medical Research Council (MRC). This UK funded award is carried out in the frame of the Global Health EDCTP3 Joint Undertaking. ES acknowledges support in part by the AI2050 program at Schmidt Futures (Grant [G-22-64476]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.